Igenerix Pharma Private Limited - Company Profile

It is a life sciences private limited company based in Noida, Uttar Pradesh, India, established in 2008.
2008 Noida, Uttar Pradesh, India Active
Last Updated:
About Igenerix Pharma Private Limited

Igenerix Pharma Private Limited, a active private limited company, was established on 05 February 2008 in Noida, Uttar Pradesh, India. Engaging in biotechnology within the hospital and medical care sector, it holds CIN: U73200UP2008PTC170816. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Arvinder Singh Sodhi (Director), Jyoti Rawal (Director). Past directors included Suraj Kumar Chowdhury, Kamal Singh Sodhi, Neeraja Shetty. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Unit No-702,Tower-1,Assotech Business Cresterra Plot No. 22,Sector 135, Expressway, Noida, Uttar Pradesh, 201301.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U73200UP2008PTC170816

  • Registration Number

    170816

  • Incorporation Date

    05 February 2008

  • Authorized Capital

    ₹1.50 Cr

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 Cr
  • Paid Up Capital ₹ 0.10 M
  • Company Age 18 Year, 8 Days
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** -11.11%
  • Profit Growth **** -56.35%
  • Ebitda **** -74.23%
  • Net Worth 7.47%
  • Total Assets -9.40%
Company report

Igenerix Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Igenerix Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Igenerix Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Arvinder Singh Sodhi Director 05 Feb 2008 Current
Jyoti Rawal Director 03 Nov 2011 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 23 Aug 2011 Past
Pramod Abcsdd Director 04 Nov 2011 Past
Pramod Abcsdd Director 18 Oct 2011 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Igenerix Pharma.

Igenerix Pharma Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 11.11% decrease. The company also saw a substantial fall in profitability, with a 56.35% decrease in profit. The company's net worth moved up by a moderate rise of 7.47%.

Igenerix Pharma revenue growth over time
Igenerix Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
-11.11%
*******
*******
*******
*******
Revenue from Operations
*******
-10.77%
*******
*******
*******
*******
Total Assets
*******
-9.40%
*******
*******
*******
*******
Profit or Loss
*******
-56.35%
*******
*******
*******
*******
Net Worth
*******
7.47%
*******
*******
*******
*******
EBITDA
*******
-74.23%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Igenerix Pharma?

In 2021, Igenerix Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Igenerix Pharma?

Unlock and access historical data on people associated with Igenerix Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Igenerix Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Igenerix Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Igenerix Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Igenerix Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Igenerix Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was completed.

  • Director Appointment

    Jyoti Rawal was appointed as a Director was appointed as a Director on 03 Nov 2011 & has been associated with this company since 14 years 3 months . was recorded as a recent event.

  • Director Appointment

    Progress on Arvinder Singh Sodhi was appointed as a Director was appointed as a Director on 05 Feb 2008 & has been associated with this company since 18 years 8 days . was documented.

  • Company Incorporation

    The activity Igenerix Pharma Private Limited was registered on 05 Feb 2008 with Roc Kanpur & aged 18 years 8 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Igenerix Pharma Private Limited?

The CIN of Igenerix Pharma Private Limited is U73200UP2008PTC170816.

Where is Igenerix Pharma Private Limited headquartered?

Igenerix Pharma Private Limited is headquartered at Unit No-702,Tower-1,Assotech Business Cresterra Plot No. 22,Sector 135, Expressway, Noida, Uttar Pradesh, 201301.

When was Igenerix Pharma Private Limited incorporated?

Igenerix Pharma Private Limited was incorporated on 05 February 2008.

Who are the current directors of Igenerix Pharma Private Limited?

The current directors of Igenerix Pharma Private Limited are

What is the primary industry of Igenerix Pharma Private Limited?

The primary industry of Igenerix Pharma Private Limited is Hospital And Medical Care.

Is Igenerix Pharma Private Limited a listed company?

Igenerix Pharma Private Limited is unlisted.

What is the capital structure of Igenerix Pharma Private Limited?

The authorized capital of Igenerix Pharma Private Limited is ₹1.50 Cr, and the paid-up capital is ₹0.10 M.

What is the compliance status of Igenerix Pharma Private Limited?

The compliance status of Igenerix Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available